Home/Terran Biosciences/Robert Fishman, MD
RF

Robert Fishman, MD

Clinical Lead

Terran Biosciences

Terran Biosciences Pipeline

DrugIndicationPhase
TerXTSchizophreniaLate-stage (Pre-Phase 3)
Idazoxan XRSchizophrenia, Alzheimer's DiseasePhase 2/3
Eplivanserin / Volinanserin (Monotherapy)Parkinson's Disease Psychosis, other neuropsychiatric illnessesPhase 3
Eplivanserin / Volinanserin (Combination)Adjunct to Psychedelic Therapy (e.g., for tailoring/aborting effects)Pre-clinical/Phase 1
Psychedelic & Empathogen Portfolio (e.g., psilocybin, MDMA prodrugs, psychoplastogens)Various Neuropsychiatric DisordersPre-clinical